[The first experience of PD-L1 testing of triple negative breast cancer with marker SP142 in Russia].
G A FrankO A KuznetsovaL E ZavalishinaYulia Yu AndreevaV V KarasevaSergey A TjulandinPublished in: Arkhiv patologii (2020)
According to the results of the first experience of testing PD-L1 in TNLM in Russia, it was possible to obtain data comparable to the same data of large international studies. RUSSCO's information and logistic support allows making this analysis available to all citizens of the country.